carbon monoxide has been researched along with penicillamine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Clerck, LS; Demedts, M; Dequeker, J; Francx, L | 1 |
| Colp, CR; Riker, J; Williams, MH | 1 |
| Bates, JN; Holmes, RW; Snyder, GD; Van Voorhis, BJ | 1 |
| Christodoulides, N; Durante, W; Kroll, MH; Peyton, KJ; Schafer, AI | 1 |
| Caudill, TK; Kanagy, NL; Resta, TC; Walker, BR | 1 |
| Clark, JE; Exon, DJ; Foresti, R; Green, CJ; Motterlini, R; Sammut, IA; Sarathchandra, P; Vesely, MJ | 1 |
| Makino, R; Suematsu, M; Suzuki, T | 1 |
| Chlopicki, S; Lomnicka, M; Marcinkiewicz, E; Motterlini, R; Olszanecki, R | 1 |
| Ganjali, MR; Moeinossadat, SR; Norouzi, P; Zeeb, M | 1 |
| Eldred, WD; Pong, WW | 1 |
10 other study(ies) available for carbon monoxide and penicillamine
| Article | Year |
|---|---|
D-penicillamine therapy and interstitial lung disease in scleroderma. A long-term followup study.
Topics: Carbon Monoxide; Diffusion; Follow-Up Studies; Humans; Lung; Penicillamine; Pulmonary Fibrosis; Respiratory Function Tests; Scleroderma, Systemic | 1987 |
Serial changes in scleroderma and idiopathic interstitial lung disease.
Topics: Adult; Aged; Arteries; Carbon Monoxide; Cyclophosphamide; Female; Humans; Lung Compliance; Male; Mercaptopurine; Middle Aged; Oxygen; Penicillamine; Prednisone; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Respiratory Function Tests; Scleroderma, Systemic; Spirometry; Time Factors; Vital Capacity | 1973 |
Nitric oxide inhibits aromatase activity: mechanisms of action.
Topics: Androstenedione; Aromatase Inhibitors; Carbon Monoxide; Cells, Cultured; Cysteine; Enzyme Inhibitors; Ethylmaleimide; Female; Gene Expression Regulation, Enzymologic; Granulosa Cells; Humans; Luteal Cells; Mercaptoethanol; Microsomes; NADP; Nitric Oxide; Penicillamine; Placenta; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Sulfhydryl Reagents | 1996 |
Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells.
Topics: Animals; Carbon Monoxide; Cells, Cultured; Cyclic GMP; Cycloheximide; Cytokines; Dactinomycin; Enzyme Inhibitors; Gene Expression Regulation; Heme Oxygenase (Decyclizing); Molsidomine; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; Penicillamine; Rats; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Time Factors; Transcription, Genetic | 1997 |
Role of endothelial carbon monoxide in attenuated vasoreactivity following chronic hypoxia.
Topics: Animals; Aorta, Thoracic; Arsenites; Carbon Monoxide; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Heme Oxygenase (Decyclizing); Hypoxia; In Vitro Techniques; Kinetics; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitroarginine; Oxadiazoles; Penicillamine; Phenylephrine; Protoporphyrins; Quinoxalines; Rats; Rats, Sprague-Dawley; Reference Values; S-Nitroso-N-Acetylpenicillamine; Sodium Compounds | 1998 |
Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1.
Topics: Animals; Aorta, Thoracic; Carbon Monoxide; Cyclic GMP; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Gene Expression; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Male; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitric Oxide Synthase; Penicillamine; Phenylephrine; Rats; Rats, Inbred Lew; Vascular Resistance; Vasoconstriction | 1998 |
Organic phosphates as a new class of soluble guanylate cyclase inhibitors.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Binding, Competitive; Carbon Monoxide; Cattle; Enzyme Activators; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Indazoles; Kinetics; Nitric Oxide; Nitric Oxide Donors; Organophosphorus Compounds; Penicillamine; Phytic Acid; Signal Transduction; Solubility | 2001 |
Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Topics: Analysis of Variance; Blood Platelets; Carbon Monoxide; Collagen; Dose-Response Relationship, Drug; Guanylate Cyclase; Humans; Indazoles; Nitric Oxide Donors; Organometallic Compounds; Oxadiazoles; Penicillamine; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Quinoxalines; Spectrophotometry; Statistics, Nonparametric; Thrombin; Time Factors | 2006 |
Selective determination of penicillamine by on-line vapor-phase generation combined with Fourier transform infrared spectrometry.
Topics: Carbon Monoxide; Iodates; Penicillamine; Pharmaceutical Preparations; Potassium Compounds; Spectroscopy, Fourier Transform Infrared | 2009 |
Interactions of the gaseous neuromodulators nitric oxide, carbon monoxide, and hydrogen sulfide in the salamander retina.
Topics: Animals; Carbon Monoxide; Cyclic GMP; Dose-Response Relationship, Drug; Drug Interactions; Hydrogen Sulfide; In Vitro Techniques; Nitric Oxide; Nitric Oxide Donors; Penicillamine; Retina; Urodela | 2009 |